Listed

Humacyte, Inc.

HUMANasdaqCIK 1818382HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$406.0k, Q2 FY2026
Operating income−$27.0m, Q2 FY2026
Net income−$36.8m, Q2 FY2026
Humacyte, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.5Revenue, Q1 FY2025, three months to 2025-03-31$517.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.3Revenue, Q2 FY2025, three months to 2025-06-30$301.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure0.8Revenue, Q3 FY2025, three months to 2025-09-30$753.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure0.5Revenue, Q4 FY2025, three months to 2025-12-31$467.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.5Revenue, Q1 FY2026, three months to 2026-03-31$495.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.4Revenue, Q2 FY2026, three months to 2026-06-30$406.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Cost of revenue$mnot reportednot reported0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure0.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.1Cost of revenue, Q1 FY2025, three months to 2025-03-31$147.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.2Cost of revenue, Q2 FY2025, three months to 2025-06-30$213.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure0.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$260.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure9.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$9.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure2.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure1.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Research and development$m18.6Research and development, Q3 FY2023, three months to 2023-09-30$18.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure20.2Research and development, Q4 FY2023, three months to 2023-12-31$20.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001818382-25-000034. Derived: 12-month figure less the 9-month figure.Report this figure21.3Research and development, Q1 FY2024, three months to 2024-03-31$21.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure23.8Research and development, Q2 FY2024, three months to 2024-06-30$23.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure22.9Research and development, Q3 FY2024, three months to 2024-09-30$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure20.7Research and development, Q4 FY2024, three months to 2024-12-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure15.4Research and development, Q1 FY2025, three months to 2025-03-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure22.0Research and development, Q2 FY2025, three months to 2025-06-30$22.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure17.3Research and development, Q3 FY2025, three months to 2025-09-30$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure14.6Research and development, Q4 FY2025, three months to 2025-12-31$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure19.5Research and development, Q1 FY2026, three months to 2026-03-31$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure18.1Research and development, Q2 FY2026, three months to 2026-06-30$18.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Selling, general and administrative$mnot reportednot reported5.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$5.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure5.7Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$5.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure7.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$7.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figurenot reported8.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$8.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure7.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$7.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure7.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$7.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figurenot reportednot reportednot reported
Operating income$m(24.6)Operating income, Q3 FY2023, three months to 2023-09-30−$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure(26.2)Operating income, Q4 FY2023, three months to 2023-12-31−$26.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001818382-25-000034. Derived: 12-month figure less the 9-month figure.Report this figure(26.6)Operating income, Q1 FY2024, three months to 2024-03-31−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure(29.5)Operating income, Q2 FY2024, three months to 2024-06-30−$29.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure(30.2)Operating income, Q3 FY2024, three months to 2024-09-30−$30.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(28.1)Operating income, Q4 FY2024, three months to 2024-12-31−$28.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(23.2)Operating income, Q1 FY2025, three months to 2025-03-31−$23.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(29.7)Operating income, Q2 FY2025, three months to 2025-06-30−$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(24.4)Operating income, Q3 FY2025, three months to 2025-09-30−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(30.8)Operating income, Q4 FY2025, three months to 2025-12-31−$30.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(28.9)Operating income, Q1 FY2026, three months to 2026-03-31−$28.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(27.0)Operating income, Q2 FY2026, three months to 2026-06-30−$27.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Interest expense$m1.5Interest expense, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure1.7Interest expense, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-28, accession 0001818382-24-000040. Derived: 12-month figure less the 9-month figure.Report this figure1.8Interest expense, Q1 FY2024, three months to 2024-03-31$1.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure2.5Interest expense, Q2 FY2024, three months to 2024-06-30$2.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure2.4Interest expense, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure2.5Interest expense, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure2.5Interest expense, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure2.6Interest expense, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure3.1Interest expense, Q4 FY2025, three months to 2025-12-31$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure2.3Interest expense, Q1 FY2026, three months to 2026-03-31$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure2.3Interest expense, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001818382-25-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Net income$m(26.0)Net income, Q3 FY2023, three months to 2023-09-30−$26.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure(25.1)Net income, Q4 FY2023, three months to 2023-12-31−$25.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001818382-25-000034. Derived: 12-month figure less the 9-month figure.Report this figure(31.9)Net income, Q1 FY2024, three months to 2024-03-31−$31.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(56.7)Net income, Q2 FY2024, three months to 2024-06-30−$56.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(39.2)Net income, Q3 FY2024, three months to 2024-09-30−$39.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(20.9)Net income, Q4 FY2024, three months to 2024-12-31−$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure39.1Net income, Q1 FY2025, three months to 2025-03-31$39.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(37.7)Net income, Q2 FY2025, three months to 2025-06-30−$37.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(17.5)Net income, Q3 FY2025, three months to 2025-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(24.8)Net income, Q4 FY2025, three months to 2025-12-31−$24.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Net income, Q1 FY2026, three months to 2026-03-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(36.8)Net income, Q2 FY2026, three months to 2026-06-30−$36.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Diluted EPS$ per share(0.25)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure(0.48)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure(0.33)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figurenot reported0.28Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(0.24)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(0.11)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(0.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Basic EPS$ per share(0.25)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figurenot reported(0.29)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure(0.48)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure(0.33)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figurenot reported0.28Basic EPS, Q1 FY2025, three months to 2025-03-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(0.24)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(0.11)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figurenot reported(0.09)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(0.16)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure

Balance sheet

Cash and equivalents$79.9m, Q2 FY2026
Long-term debt$36.3m, Q2 FY2026
Shareholders' equity$31.3m, Q2 FY2026
Humacyte, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m100.0Cash and equivalents, Q3 FY2023, at 2023-09-30$100.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure80.4Cash and equivalents, FY2023, at 2023-12-31$80.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001818382-25-000034.Report this figure116Cash and equivalents, Q1 FY2024, at 2024-03-31$115.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure93.6Cash and equivalents, Q2 FY2024, at 2024-06-30$93.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001818382-24-000156.Report this figure20.6Cash and equivalents, Q3 FY2024, at 2024-09-30$20.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure44.9Cash and equivalents, FY2024, at 2024-12-31$44.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figure62.8Cash and equivalents, Q1 FY2025, at 2025-03-31$62.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure38.0Cash and equivalents, Q2 FY2025, at 2025-06-30$38.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure19.5Cash and equivalents, Q3 FY2025, at 2025-09-30$19.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure50.5Cash and equivalents, FY2025, at 2025-12-31$50.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure48.5Cash and equivalents, Q1 FY2026, at 2026-03-31$48.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure79.9Cash and equivalents, Q2 FY2026, at 2026-06-30$79.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Current assets$m103Current assets, Q3 FY2023, at 2023-09-30$102.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure83.3Current assets, FY2023, at 2023-12-31$83.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001818382-25-000034.Report this figure118Current assets, Q1 FY2024, at 2024-03-31$117.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure96.1Current assets, Q2 FY2024, at 2024-06-30$96.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001818382-24-000156.Report this figure23.0Current assets, Q3 FY2024, at 2024-09-30$23.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure47.9Current assets, FY2024, at 2024-12-31$47.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figure73.7Current assets, Q1 FY2025, at 2025-03-31$73.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure51.7Current assets, Q2 FY2025, at 2025-06-30$51.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure41.4Current assets, Q3 FY2025, at 2025-09-30$41.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure67.8Current assets, FY2025, at 2025-12-31$67.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure63.6Current assets, Q1 FY2026, at 2026-03-31$63.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure92.8Current assets, Q2 FY2026, at 2026-06-30$92.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Total assets$m149Total assets, Q3 FY2023, at 2023-09-30$149.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure128Total assets, FY2023, at 2023-12-31$128.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001818382-25-000034.Report this figure161Total assets, Q1 FY2024, at 2024-03-31$161.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure138Total assets, Q2 FY2024, at 2024-06-30$138.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001818382-24-000156.Report this figure115Total assets, Q3 FY2024, at 2024-09-30$114.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure138Total assets, FY2024, at 2024-12-31$137.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figure163Total assets, Q1 FY2025, at 2025-03-31$162.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure139Total assets, Q2 FY2025, at 2025-06-30$138.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure91.5Total assets, Q3 FY2025, at 2025-09-30$91.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure116Total assets, FY2025, at 2025-12-31$116.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure111Total assets, Q1 FY2026, at 2026-03-31$110.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure138Total assets, Q2 FY2026, at 2026-06-30$138.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Current liabilities$m15.1Current liabilities, Q3 FY2023, at 2023-09-30$15.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure18.4Current liabilities, FY2023, at 2023-12-31$18.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001818382-25-000034.Report this figure14.1Current liabilities, Q1 FY2024, at 2024-03-31$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure17.8Current liabilities, Q2 FY2024, at 2024-06-30$17.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001818382-24-000156.Report this figure20.9Current liabilities, Q3 FY2024, at 2024-09-30$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure20.0Current liabilities, FY2024, at 2024-12-31$20.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figure20.0Current liabilities, Q1 FY2025, at 2025-03-31$20.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure21.1Current liabilities, Q2 FY2025, at 2025-06-30$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure25.6Current liabilities, Q3 FY2025, at 2025-09-30$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure18.4Current liabilities, FY2025, at 2025-12-31$18.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure16.2Current liabilities, Q1 FY2026, at 2026-03-31$16.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure14.9Current liabilities, Q2 FY2026, at 2026-06-30$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Total liabilities$m112Total liabilities, Q3 FY2023, at 2023-09-30$112.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure115Total liabilities, FY2023, at 2023-12-31$114.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001818382-25-000034.Report this figure135Total liabilities, Q1 FY2024, at 2024-03-31$135.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure167Total liabilities, Q2 FY2024, at 2024-06-30$166.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001818382-24-000156.Report this figure178Total liabilities, Q3 FY2024, at 2024-09-30$178.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure191Total liabilities, FY2024, at 2024-12-31$190.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figure127Total liabilities, Q1 FY2025, at 2025-03-31$126.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure135Total liabilities, Q2 FY2025, at 2025-06-30$134.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure96.3Total liabilities, Q3 FY2025, at 2025-09-30$96.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure113Total liabilities, FY2025, at 2025-12-31$113.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure98.9Total liabilities, Q1 FY2026, at 2026-03-31$98.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure107Total liabilities, Q2 FY2026, at 2026-06-30$106.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figurenot reportednot reportednot reported35.4Long-term debt, FY2025, at 2025-12-31$35.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure35.9Long-term debt, Q1 FY2026, at 2026-03-31$35.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure36.3Long-term debt, Q2 FY2026, at 2026-06-30$36.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure
Shareholders' equity$m37.0Shareholders' equity, Q3 FY2023, at 2023-09-30$37.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure13.5Shareholders' equity, FY2023, at 2023-12-31$13.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001818382-26-000004.Report this figure26.2Shareholders' equity, Q1 FY2024, at 2024-03-31$26.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(28.3)Shareholders' equity, Q2 FY2024, at 2024-06-30−$28.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(63.7)Shareholders' equity, Q3 FY2024, at 2024-09-30−$63.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure(52.7)Shareholders' equity, FY2024, at 2024-12-31−$52.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure36.0Shareholders' equity, Q1 FY2025, at 2025-03-31$36.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure4.1Shareholders' equity, Q2 FY2025, at 2025-06-30$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure(4.8)Shareholders' equity, Q3 FY2025, at 2025-09-30−$4.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure3.1Shareholders' equity, FY2025, at 2025-12-31$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure11.6Shareholders' equity, Q1 FY2026, at 2026-03-31$11.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure31.3Shareholders' equity, Q2 FY2026, at 2026-06-30$31.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure

Cash flow

Operating cash flow−$22.1m, Q2 FY2026
Capital expenditure$104.0k, Q2 FY2026
Humacyte, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001818382-24-000199. Derived: 9-month figure less the 6-month figure.Report this figure(19.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001818382-25-000034. Derived: 12-month figure less the 9-month figure.Report this figure(27.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$27.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure(21.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001818382-25-000125. Derived: 6-month figure less the 3-month figure.Report this figure(22.9)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$22.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001818382-25-000132. Derived: 9-month figure less the 6-month figure.Report this figure(26.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(28.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$28.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(26.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$26.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-347022. Derived: 6-month figure less the 3-month figure.Report this figure(23.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$23.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001818382-25-000132. Derived: 9-month figure less the 6-month figure.Report this figure(26.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(25.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$25.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure(22.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-347022. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$493.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001818382-24-000199. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$150.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001818382-25-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$391.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$184.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001818382-25-000125. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$934.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001818382-25-000132. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$63.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$228.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$568.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-347022. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$49.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001818382-25-000132. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$39.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001818382-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$175.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$104.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-347022. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)234.18m, Q2 FY2026
Humacyte, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares103Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30103,031,980 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001818382-23-000162.Report this figure103Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31103,263,528 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001818382-24-000056.Report this figure103Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30103,361,501 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001818382-24-000156.Report this figure103Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30103,444,246 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001818382-24-000199.Report this figure108Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31108,246,008 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001818382-25-000076.Report this figure119Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30119,174,681 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001818382-25-000125.Report this figure119Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30119,408,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure132Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31131,759,302 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure155Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30155,437,281 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure158Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30158,313,290 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001818382-25-000132.Report this figure198Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31197,846,786 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221755.Report this figure234Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30234,182,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure

Shares outstanding: 277.80mShares outstanding, period not labelled, at 2026-08-10277,798,105 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-347022.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.